Journal of Blood and Lymph Research

The journal aims to provide a multidisciplinary platform for researchers, clinicians, healthcare professionals, and scientists to communicate innovative findings, clinical observations, emerging concepts, and advances in the diagnosis, prevention, and management of diseases affecting the blood, bone marrow, lymphatic system, and related immune and hematological pathways.

The scope of the journal includes, but is not limited to:

Clinical and experimental hematology
Red blood cell disorders and anemias
White blood cell disorders
Platelet disorders
Coagulation and bleeding disorders
Thrombosis and thromboembolic diseases
Hemophilia and inherited blood disorders
Leukemia and related hematological malignancies
Lymphoma and lymphoproliferative disorders
Hodgkin and non-Hodgkin lymphoma
Multiple myeloma and plasma-cell disorders
Myelodysplastic and myeloproliferative disorders
Bone marrow diseases and disorders
Hematopoietic stem cell transplantation
Blood transfusion and transfusion medicine
Blood banking and immunohematology
Hematopathology
Molecular and cellular hematology
Immunohematology and hematological immunology
Lymphatic biology and lymphatic disorders
Lymphatic circulation and lymphangiogenesis
Hematological and lymphatic cancers
Pediatric and geriatric hematology
Genetic and genomic aspects of blood disorders
Laboratory diagnosis and biomarkers
Novel diagnostic and therapeutic approaches
Precision medicine in hematology
Epidemiology and public health in blood and lymphatic disorders
Clinical trials and translational research
Rare and emerging hematological diseases

The journal welcomes original research, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, clinical perspectives, commentaries, letters to the editor, and other scientifically relevant contributions.

The journal particularly encourages interdisciplinary and translational research that connects laboratory discoveries with clinical applications and contributes to improved diagnosis, treatment, and patient outcomes.

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Responsibilities of the editors

This Journal is always a collaborative effort. Managing challenges of research integrity and publishing ethics in the journal is no exception. Legal concerns may arise as a result of these issues.

Confidentiality

The corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate, are the only people who should know about a manuscript that has been submitted to them.

Responsibilities of reviewers

The peer-reviewing process helps the editor and editorial board make editorial judgments, and it may also help the author improve their manuscript. Manuscripts submitted for review must be treated as private papers.

Manuscripts submitted to the Journal of Blood and Lymph Research should be original contributions that have not been published previously and are not simultaneously under consideration by another journal.

Manuscripts should be submitted electronically through the journal's designated submission system or by email, as specified by the journal.

Submission of a manuscript indicates that all authors have reviewed and approved the submitted version and agree to its consideration for publication.

Registered Address: 91 Ivy Lane, Waltham Cros, United Kingdom, EN8
Address: Probe Publisher, 45 Highfield Road LONDON, UK
Email: contact@probejournals.com
Phone: +44 3455007136